Matches in Wikidata for { <http://www.wikidata.org/entity/Q90806383> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q90806383 description "article scientifique publié en 2020" @default.
- Q90806383 description "artículu científicu espublizáu en marzu de 2020" @default.
- Q90806383 description "scientific article published on 31 March 2020" @default.
- Q90806383 description "wetenschappelijk artikel" @default.
- Q90806383 description "наукова стаття, опублікована 31 березня 2020" @default.
- Q90806383 name "Doxorubicin and Olaratumab Versus Doxorubicin, Ifosfamide, and Mesna for Treatment of Advanced Soft Tissue Sarcomas" @default.
- Q90806383 name "Doxorubicin and Olaratumab Versus Doxorubicin, Ifosfamide, and Mesna for Treatment of Advanced Soft Tissue Sarcomas" @default.
- Q90806383 type Item @default.
- Q90806383 label "Doxorubicin and Olaratumab Versus Doxorubicin, Ifosfamide, and Mesna for Treatment of Advanced Soft Tissue Sarcomas" @default.
- Q90806383 label "Doxorubicin and Olaratumab Versus Doxorubicin, Ifosfamide, and Mesna for Treatment of Advanced Soft Tissue Sarcomas" @default.
- Q90806383 prefLabel "Doxorubicin and Olaratumab Versus Doxorubicin, Ifosfamide, and Mesna for Treatment of Advanced Soft Tissue Sarcomas" @default.
- Q90806383 prefLabel "Doxorubicin and Olaratumab Versus Doxorubicin, Ifosfamide, and Mesna for Treatment of Advanced Soft Tissue Sarcomas" @default.
- Q90806383 P1433 Q90806383-BDDE5F7E-DEFD-411C-804E-49BD2CC763ED @default.
- Q90806383 P1476 Q90806383-1CBF73F0-7987-4E2A-ABFD-511106F3A3DF @default.
- Q90806383 P2093 Q90806383-28CC8267-0989-4916-854A-6153AC89FED5 @default.
- Q90806383 P2093 Q90806383-3241D44F-CE47-43FD-A8D2-D8451B5B0492 @default.
- Q90806383 P2093 Q90806383-3AECAD5D-44C8-45AC-A131-E6DFECECC531 @default.
- Q90806383 P2093 Q90806383-705AD38A-3E0C-45DC-BE2C-6B9B1DC65261 @default.
- Q90806383 P2093 Q90806383-76E58513-490C-4F51-85FB-28CFF05B0C53 @default.
- Q90806383 P2093 Q90806383-CFF21A58-68BE-418C-A3FE-323CCB3CB8EE @default.
- Q90806383 P31 Q90806383-15715C62-84B7-468B-83EE-0339A1B574A2 @default.
- Q90806383 P356 Q90806383-611FB754-C6E7-4A6C-9FF0-E96995A0D228 @default.
- Q90806383 P577 Q90806383-3995319A-6871-4700-B3F3-ECD0BA57CADF @default.
- Q90806383 P698 Q90806383-E8FB2CC8-4F2F-4BB1-ACE4-CC39E046449F @default.
- Q90806383 P921 Q90806383-1B1FA1F0-9F3F-41EB-9771-F7C3D7C0DCF7 @default.
- Q90806383 P921 Q90806383-7849CBFF-2CEC-4031-8748-38282C900D85 @default.
- Q90806383 P921 Q90806383-834A00A8-4668-40F2-99D5-71BCD427875E @default.
- Q90806383 P356 COC.0000000000000690 @default.
- Q90806383 P698 32235164 @default.
- Q90806383 P1433 Q2886177 @default.
- Q90806383 P1476 "Doxorubicin and Olaratumab Versus Doxorubicin, Ifosfamide, and Mesna for Treatment of Advanced Soft Tissue Sarcomas" @default.
- Q90806383 P2093 "Elizabeth T Loggers" @default.
- Q90806383 P2093 "Kathryn J Hammer" @default.
- Q90806383 P2093 "Lee D Cranmer" @default.
- Q90806383 P2093 "Michael J Wagner" @default.
- Q90806383 P2093 "Seth M Pollack" @default.
- Q90806383 P2093 "Vanessa C Copeland" @default.
- Q90806383 P31 Q13442814 @default.
- Q90806383 P356 "10.1097/COC.0000000000000690" @default.
- Q90806383 P577 "2020-03-31T00:00:00Z" @default.
- Q90806383 P698 "32235164" @default.
- Q90806383 P921 Q18936 @default.
- Q90806383 P921 Q418560 @default.
- Q90806383 P921 Q424997 @default.